• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲硝唑治疗晚期结直肠癌的II期研究。

Phase II study of metronidazole therapy for advanced colorectal carcinoma.

作者信息

Frytak S, Moertel C G, Childs D S, Schutt A J, Albers J W

出版信息

Cancer Treat Rep. 1978 Mar;62(3):483-5.

PMID:348320
Abstract

Thirty-two patients with advanced carcinoma of the colon or rectum were given metronidazole orally at a dose of 500-1000 mg/m2 three times a day for 7 consecutive days every 6 weeks. The dose-limiting toxic effects consisted of severe nausea, vomiting, and major motor seizures. Mild peripheral neurotoxic effects were also noted. No objective responses were noted in any of the 32 patients treated. High-dose metronidazole would not seem to have any role in the treatment of advanced colorectal carcinoma and may cause serious neurotoxicity.

摘要

32例晚期结肠癌或直肠癌患者口服甲硝唑,剂量为500 - 1000mg/m²,每日3次,连续7天,每6周重复一次。剂量限制性毒性反应包括严重恶心、呕吐和严重运动性癫痫发作。还观察到轻度周围神经毒性反应。接受治疗的32例患者均未出现客观缓解。高剂量甲硝唑似乎对晚期结直肠癌的治疗没有任何作用,且可能导致严重神经毒性。

相似文献

1
Phase II study of metronidazole therapy for advanced colorectal carcinoma.甲硝唑治疗晚期结直肠癌的II期研究。
Cancer Treat Rep. 1978 Mar;62(3):483-5.
2
Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Cancer Treat Rep. 1983 Nov;67(11):1001-8.
3
Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
Cancer Treat Rep. 1987 Jun;71(6):649-50.
4
Phase II evaluation of metoprine with leucovorin rescue in patients with advanced colorectal carcinoma.亚叶酸解救的美托普林用于晚期结直肠癌患者的II期评估。
Cancer Clin Trials. 1981 Fall;4(3):281-3.
5
Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma.6-重氮-5-氧代-L-正亮氨酸(DON)用于晚期结直肠癌患者的II期评估。
Am J Clin Oncol. 1982 Oct;5(5):541-3.
6
Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.4'-表阿霉素用于晚期结直肠癌患者的II期评估。
Cancer Treat Rep. 1982 Sep;66(9):1757-8.
7
Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.阿西维辛治疗结直肠癌的II期研究:加拿大国立癌症研究所的一项研究
Cancer Treat Rep. 1984 Sep;68(9):1121-3.
8
Phase III study of ICRF-159 versus 5-FU in the treatment of advanced metastatic colorectal carcinoma.ICRF-159与5-氟尿嘧啶治疗晚期转移性结直肠癌的III期研究。
Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1047-9.
9
Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
Cancer Treat Rep. 1978 Apr;62(4):563-5.
10
Phase II study of 3-deazauridine in advanced colorectal adenocarcinoma.3-去氮尿苷治疗晚期结肠腺癌的II期研究。
Am J Clin Oncol. 1982 Feb;5(1):69-71.

引用本文的文献

1
In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.抗癌药物与米索硝唑或甲硝唑在体内的相互作用:甲氨蝶呤、5-氟尿嘧啶和阿霉素。
Br J Cancer. 1980 Dec;42(6):861-70. doi: 10.1038/bjc.1980.334.
2
Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.甲硝唑在厌氧菌感染中的应用:对其活性、药代动力学及治疗用途的综述
Drugs. 1978 Nov;16(5):387-417. doi: 10.2165/00003495-197816050-00002.